|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 253, Issue 4 E370-E375, Copyright © 1987 by American Physiological Society
ARTICLES |
M. A. McElligott, J. E. Mulder, L. Y. Chaung and A. Barreto Jr
Department of Animal Drug Discovery, Merck Sharp & Dohme Research Laboratories, Rahway 07065.
The role of insulin as a possible mediator of the beta-adrenergic agonist stimulation of muscle growth was investigated. To exclude possible action of the beta-agonist on the pancreatic release of insulin, diabetes was induced in rats by a streptozotocin injection (100 mg/kg). Insulin levels were almost not detectable in these rats. Feeding either normal diet or diet containing the beta-adrenergic agonist clenbuterol (10 parts/million) did not alter plasma insulin concentrations. The effects of clenbuterol on muscle and weight gain were determined in diabetic rats given daily insulin replacement (D + I) and fed either a normal diet or clenbuterol-treated diet. Clenbuterol, fed for 1 wk, increased the wet weight of the gastrocnemius, soleus, and extensor digitorum longus muscles (15-23%) in both normal and D + I rats. Although clenbuterol increased body weight gain, it did not alter feed consumption and, therefore, feed efficiency (g gain/g food) was improved. Activities of cathepsin B and N-acetyl-beta-glucosaminidase, but not cathepsin D, were elevated in the soleus muscles of clenbuterol-treated rats. The clenbuterol-induced increase in muscle growth in the insulin-replaced diabetic rats indicated that this beta-adrenergic agonist effect was not mediated by an alteration of circulating levels of insulin, secondary to beta-agonist action on pancreatic insulin release.
This article has been cited by other articles:
![]() |
G. S. Lynch and J. G. Ryall Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease Physiol Rev, April 1, 2008; 88(2): 729 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. C. Navegantes, N. M. Z. Resano, R. H. Migliorini, and I. C. Kettelhut Catecholamines inhibit Ca2+-dependent proteolysis in rat skeletal muscle through {beta}2-adrenoceptors and cAMP Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E449 - E454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Eisemann and D. G. Bristol Change in Insulin Sensitivity or Responsiveness Is Not a Major Component of the Mechanism of Action of Ractopamine in Beef Steers J. Nutr., March 1, 1998; 128(3): 505 - 511. [Abstract] [Full Text] |
||||
![]() |
A. W. Bell, D. E. Bauman, D. H. Beermann, and R. J. Harrell Nutrition, Development and Efficacy of Growth Modifiers in Livestock Species J. Nutr., February 1, 1998; 128(2): 360 - 360. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |